About
Marleen van den Horst is an IP & Technology partner at La Gro with over 25 years’ experience in multi‑jurisdictional patent litigation and, since 2023, cases before the Unified Patent Court (UPC). She is internationally known for patent, regulatory and product liability work in life sciences and advises on European litigation strategy for high‑tech/telecoms (including SEP/FRAND issues).
Practice areas
Intellectual PropertyLitigationHealthcare & Life SciencesTechnologyRegulatoryProduct Liability
Office
Expertise
Multi-jurisdictional patent litigationUPC (Unified Patent Court) casesPatent/SPC litigationLife sciences pharmaceuticals (e.g. escitalopram, glatiramer acetate, rivastigmine, zoledronate, fingolimod, eculizumab)CRISPR-Cas9 technologyHigh tech/telecoms (SEP patents and FRAND)Regulatory adviceProduct liability
Education
- J.D.